CD38 is a 45 kDa transmembrane glycoprotein, which appears to utilize the B cell antigen receptor (BCR) signaling pathway to induce survival and proliferation in CLL cells [6]. Here, BCR is linked to B-cell chronic lymphocytic leukemia.